Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Kestra Medical Technologies (KMTS) Cost of Revenue (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Cost of Revenue for 3 consecutive years, with $11.6 million as the latest value for Q1 2026.

  • Quarterly Cost of Revenue rose 36.32% to $11.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $42.9 million through Jan 2026, up 23.79% year-over-year, with the annual reading at $35.6 million for FY2025, 29.7% up from the prior year.
  • Cost of Revenue for Q1 2026 was $11.6 million at Kestra Medical Technologies, up from $11.1 million in the prior quarter.
  • The five-year high for Cost of Revenue was $11.6 million in Q1 2026, with the low at $7.4 million in Q1 2024.
  • Average Cost of Revenue over 3 years is $9.4 million, with a median of $8.9 million recorded in 2024.
  • The sharpest move saw Cost of Revenue rose 10.89% in 2025, then surged 36.32% in 2026.
  • Over 3 years, Cost of Revenue stood at $8.9 million in 2024, then increased by 25.46% to $11.1 million in 2025, then grew by 4.53% to $11.6 million in 2026.
  • According to Business Quant data, Cost of Revenue over the past three periods came in at $11.6 million, $11.1 million, and $10.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.